tradingkey.logo

Bio Rad Laboratories Inc

BIO

284.600USD

+42.650+17.63%
Fechamento 08/01, 16:00ETCotações atrasadas em 15 min
7.86BValor de mercado
PerdaP/L TTM

Bio Rad Laboratories Inc

284.600

+42.650+17.63%
Mais detalhes de Bio Rad Laboratories Inc Empresa
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Informações da empresa
Código da empresaBIO
Nome da EmpresaBio Rad Laboratories Inc
Data de listagemMar 17, 1980
Fundado em1975
CEOMr. Norman D. Schwartz
Número de funcionários7700
Tipo de títulosOrdinary Share
Fim do ano fiscalMar 17
Endereço1000 Alfred Nobel Dr
CidadeHERCULES
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal94547
Telefone15107247000
Sitehttps://www.bio-rad.com/
Código da empresaBIO
Data de listagemMar 17, 1980
Fundado em1975
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
442.79K
+0.49%
Ms. Colleen Corey
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
18.48K
+7.29%
Mr. Michael Crowley
Mr. Michael Crowley
Executive Vice President - Global Commercial Operations
Executive Vice President - Global Commercial Operations
8.17K
--
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Lead Independent Director
Lead Independent Director
808.00
+61.60%
Mr. Sedat Evran
Mr. Sedat Evran
Executive Vice President - Global Supply Chain
Executive Vice President - Global Supply Chain
729.00
+3545.00%
Mr. Arnold A. Pinkston
Mr. Arnold A. Pinkston
Independent Director
Independent Director
308.00
--
Mr. Jeffrey L. (Jeff) Edwards
Mr. Jeffrey L. (Jeff) Edwards
Independent Director
Independent Director
308.00
--
Ms. Eva Anette Engelhardt
Ms. Eva Anette Engelhardt
Executive Vice President, President of Clinical Diagnostics Group
Executive Vice President, President of Clinical Diagnostics Group
157.00
--
Ms. Courtney C Enloe
Ms. Courtney C Enloe
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
119.00
--
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
442.79K
+0.49%
Ms. Colleen Corey
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
18.48K
+7.29%
Mr. Michael Crowley
Mr. Michael Crowley
Executive Vice President - Global Commercial Operations
Executive Vice President - Global Commercial Operations
8.17K
--
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Lead Independent Director
Lead Independent Director
808.00
+61.60%
Mr. Sedat Evran
Mr. Sedat Evran
Executive Vice President - Global Supply Chain
Executive Vice President - Global Supply Chain
729.00
+3545.00%
Mr. Arnold A. Pinkston
Mr. Arnold A. Pinkston
Independent Director
Independent Director
308.00
--
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Sem dados
Por RegiãoUSD
Nome
Receita
Proporção
United States
241.70M
41.29%
Europe
199.80M
34.13%
APAC
104.10M
17.78%
Other
39.80M
6.80%
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: sex, 16 de mai
Atualizado em: sex, 16 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
First Eagle Investment Management, L.L.C.
10.36%
The Vanguard Group, Inc.
8.59%
Alice N. Schwartz Revocable Trust
8.04%
BlackRock Institutional Trust Company, N.A.
7.42%
Schwartz (Alice N)
4.29%
Other
61.29%
Investidores
Investidores
Proporção
First Eagle Investment Management, L.L.C.
10.36%
The Vanguard Group, Inc.
8.59%
Alice N. Schwartz Revocable Trust
8.04%
BlackRock Institutional Trust Company, N.A.
7.42%
Schwartz (Alice N)
4.29%
Other
61.29%
Tipos de investidores
Investidores
Proporção
Investment Advisor/Hedge Fund
42.73%
Investment Advisor
39.24%
Individual Investor
8.14%
Corporation
8.05%
Hedge Fund
5.69%
Research Firm
1.93%
Bank and Trust
1.28%
Pension Fund
1.16%
Sovereign Wealth Fund
0.64%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
1114
24.05M
108.63%
-2.78M
2025Q1
1170
23.54M
106.01%
-2.87M
2024Q4
1159
23.02M
100.37%
-3.90M
2024Q3
1144
23.65M
103.58%
-2.77M
2024Q2
1163
23.92M
102.32%
-878.39K
2024Q1
1175
22.36M
95.71%
-2.57M
2023Q4
1205
22.70M
94.11%
-2.35M
2023Q3
1189
22.91M
95.16%
-1.86M
2023Q2
1192
23.05M
93.93%
-1.30M
2023Q1
1200
23.34M
95.18%
-1.09M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
First Eagle Investment Management, L.L.C.
2.29M
10.36%
+728.07K
+46.49%
Apr 30, 2025
The Vanguard Group, Inc.
1.90M
8.59%
-10.12K
-0.53%
Mar 31, 2025
Alice N. Schwartz Revocable Trust
1.78M
8.04%
-3.19K
-0.18%
Feb 24, 2025
BlackRock Institutional Trust Company, N.A.
1.64M
7.42%
-4.83K
-0.29%
Mar 31, 2025
Schwartz (Alice N)
951.13K
4.3%
+2.20K
+0.23%
Feb 24, 2025
Veritas Asset Management LLP
913.12K
4.12%
-63.70K
-6.52%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
877.04K
3.96%
+130.92K
+17.55%
Mar 31, 2025
Ariel Investments, LLC
724.66K
3.27%
+164.14K
+29.28%
Mar 31, 2025
State Street Global Advisors (US)
694.52K
3.14%
+4.36K
+0.63%
Mar 31, 2025
EARNEST Partners, LLC
599.62K
2.71%
-18.43K
-2.98%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: há 11 horas
Atualizado em: há 11 horas
Nome
Proporção
Parnassus Value Select ETF
2.78%
VanEck Morningstar ESG Moat ETF
2.29%
First Trust Indxx Medical Devices ETF
1.89%
Alger Russell Innovation ETF
1.78%
ROBO Global Healthcare Technology & Innovation ETF
1.57%
VanEck Morningstar Wide Moat Growth ETF
1.16%
Schwab Ariel Opportunities ETF
1.14%
Pacer US Export Leaders ETF
1.02%
FPA Global Equity ETF
1.01%
First Eagle Global Equity ETF
0.84%
Ver Mais
Parnassus Value Select ETF
Proporção2.78%
VanEck Morningstar ESG Moat ETF
Proporção2.29%
First Trust Indxx Medical Devices ETF
Proporção1.89%
Alger Russell Innovation ETF
Proporção1.78%
ROBO Global Healthcare Technology & Innovation ETF
Proporção1.57%
VanEck Morningstar Wide Moat Growth ETF
Proporção1.16%
Schwab Ariel Opportunities ETF
Proporção1.14%
Pacer US Export Leaders ETF
Proporção1.02%
FPA Global Equity ETF
Proporção1.01%
First Eagle Global Equity ETF
Proporção0.84%
Dividendo
Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI